# TMED7

## Overview
TMED7 is a gene that encodes the transmembrane p24 trafficking protein 7, a member of the p24 family of proteins. This protein is integral to cellular processes, particularly in the regulation of Toll-like receptor 4 (TLR4) signaling, which is crucial for the innate immune response. As a transmembrane protein, TMED7 is involved in the transport and sorting of specific TLRs between the endoplasmic reticulum and the Golgi apparatus, facilitating their movement to the cell surface. The protein's structure includes a GOLD domain, coiled-coil domain, and two transmembrane domains, which are essential for its function in vesicular trafficking and protein-protein interactions. TMED7's role in modulating immune responses and its involvement in various signaling pathways underscore its significance in maintaining immune homeostasis and its potential implications in diseases such as sepsis and cancer (Knopf2024RHBDL4triggered; Doyle2012The; LiaunardyJopeace2014The).

## Structure
TMED7 is a 224 amino acid protein characterized by several distinct domains and structural features. It contains a GOLD domain, which is involved in protein-protein interactions and projects into the cytosol, facilitating interactions with other proteins such as the TLR4/TRAM/TRIF complex (Doyle2012The; LiaunardyJopeace2014The). The protein also has a coiled-coil domain and two transmembrane domains, one near the N-terminus (amino acids 17-34) and another near the C-terminus (amino acids 186-207), which are essential for its membrane-spanning capability (Doyle2012The).

TMED7 is glycosylated, likely at Asn 103 within the GOLD domain, and contains conserved cysteine residues that may form disulfide bridges, contributing to its stability and function (LiaunardyJopeace2014The). The protein's cytoplasmic tail includes a motif involved in binding to COP II, which is crucial for its role in vesicular trafficking (LiaunardyJopeace2014The). TMED7 can form homodimers and potentially heterodimers with other TMED family members, which is important for its function in TLR4 trafficking (LiaunardyJopeace2014The). The protein's structure and post-translational modifications are integral to its role in cellular signaling and trafficking pathways.

## Function
TMED7, a member of the p24 protein family, plays a crucial role in the regulation of Toll-like receptor 4 (TLR4) signaling, which is essential for the innate immune response. TMED7 functions as a cargo receptor, facilitating the transport of newly synthesized TLR4 from the endoplasmic reticulum (ER) to the cell surface via COPII vesicles. This process is vital for the proper functioning of TLR4 signaling, which coordinates the inflammatory response to bacterial lipopolysaccharide (LPS) (Knopf2024RHBDL4triggered).

In healthy human cells, TMED7 is primarily localized in the Golgi and endosomal structures. Upon LPS stimulation, it traffics into the endosomal network, where it interacts with TRAM and TAG, disrupting the TRIF/TRAM complex and leading to the degradation of TLR4. This action serves as a negative regulatory mechanism to prevent excessive immune responses (Doyle2012The).

TMED7 is also involved in the MyD88-independent TLR4 signaling pathway, acting as an inhibitor by preventing TRAM-induced ISRE activation and IRF3 phosphorylation. This regulatory role is crucial for maintaining immune homeostasis and preventing overactivation of TLR4 signaling pathways (Doyle2012The).

## Clinical Significance
TMED7 plays a significant role in regulating Toll-like receptor 4 (TLR4) signaling, which is crucial for immune responses. Alterations in TMED7 expression or its interactions can impact inflammatory signaling pathways, potentially contributing to various diseases. TMED7 negatively regulates TLR4 signaling by interacting with TRAM and TAG, disrupting the TRIF-TRAM complex, and promoting TLR4 degradation. This regulation is essential for controlling immune responses to lipopolysaccharide (LPS) from Gram-negative bacteria, which, if excessive, can lead to conditions such as Gram-negative sepsis, rheumatoid arthritis, and atherosclerosis (Doyle2012The; Aber2019Transmembrane).

Increased TMED7 levels, due to RHBDL4 ablation, enhance TLR4 cell surface localization and signaling, resulting in elevated pro-inflammatory cytokine expression, such as TNFα and IL-6, upon LPS stimulation. This heightened inflammatory response is associated with reduced survival in RHBDL4 knockout mice following LPS-induced septic shock, indicating the importance of TMED7 regulation in preventing excessive inflammation (Knopf2024RHBDL4triggered).

TMED7 is also implicated in cancer, as it is upregulated in metastatic nasopharyngeal carcinoma cell lines, suggesting a role in immunosuppression and anti-tumor immunity (Doyle2012The). Additionally, TMED7 is linked to poor prognosis in head and neck squamous carcinoma, where its activation might improve outcomes (Gao2022TMED2910).

## Interactions
TMED7, a member of the p24 family, is involved in the trafficking of Toll-Like Receptors (TLRs) and interacts with several proteins in this process. TMED7 forms complexes with TLR2, TLR4, and TLR5, which are primarily cell surface signaling receptors, but does not interact with TLR3 or TLR9, which signal from endosomal compartments (Holm2022Anterograde). This selective interaction suggests a role for TMED7 in the transport and sorting of specific TLRs between the endoplasmic reticulum (ER) and Golgi apparatus (Holm2022Anterograde).

TMED7 also interacts with TLR4 through its luminal coiled-coil and GOLD domains, facilitating TLR4's transport to the plasma membrane (LiaunardyJopeace2014The). This interaction is crucial for TLR4 signaling, as TMED7 depletion reduces TLR4 signaling mediated by the MyD88 adaptor protein (LiaunardyJopeace2014The). TMED7 forms oligomers through its coiled-coil domain and may heterodimerize with other TMED family members, such as TMED2, TMED9, and TMED10, which are involved in anterograde and retrograde transport processes (LiaunardyJopeace2014The). These interactions highlight TMED7's role in the regulation of TLR trafficking and signaling.


## References


[1. (Gao2022TMED2910) Wen Gao, Zhe-Wen Zhang, Hong-Yi Wang, Xin-Di Li, Wei-Ting Peng, Hao-Yu Guan, Yu-Xuan Liao, and An Liu. Tmed2/9/10 serve as biomarkers for poor prognosis in head and neck squamous carcinoma. Frontiers in Genetics, June 2022. URL: http://dx.doi.org/10.3389/fgene.2022.895281, doi:10.3389/fgene.2022.895281. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2022.895281)

[2. (LiaunardyJopeace2014The) Ardiyanto Liaunardy-Jopeace, Clare E. Bryant, and Nicholas J. Gay. The cop ii adaptor protein tmed7 is required to initiate and mediate the delivery of tlr4 to the plasma membrane. Science Signaling, July 2014. URL: http://dx.doi.org/10.1126/scisignal.2005275, doi:10.1126/scisignal.2005275. This article has 46 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1126/scisignal.2005275)

[3. (Aber2019Transmembrane) Rachel Aber, Wesley Chan, Sevane Mugisha, and Loydie A. Jerome-Majewska. Transmembrane emp24 domain proteins in development and disease. Genetics Research, 2019. URL: http://dx.doi.org/10.1017/s0016672319000090, doi:10.1017/s0016672319000090. This article has 39 citations and is from a peer-reviewed journal.](https://doi.org/10.1017/s0016672319000090)

[4. (Knopf2024RHBDL4triggered) Julia D. Knopf, Susanne S. Steigleder, Friederike Korn, Nathalie Kühnle, Marina Badenes, Marina Tauber, Sebastian J. Theobald, Jan Rybniker, Colin Adrain, and Marius K. Lemberg. Rhbdl4-triggered downregulation of copii adaptor protein tmed7 suppresses tlr4-mediated inflammatory signaling. Nature Communications, March 2024. URL: http://dx.doi.org/10.1038/s41467-024-45615-2, doi:10.1038/s41467-024-45615-2. This article has 1 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-024-45615-2)

[5. (Doyle2012The) Sarah L. Doyle, Harald Husebye, Dympna J. Connolly, Terje Espevik, Luke A.J. O’Neill, and Anne F. McGettrick. The gold domain-containing protein tmed7 inhibits tlr4 signalling from the endosome upon lps stimulation. Nature Communications, February 2012. URL: http://dx.doi.org/10.1038/ncomms1706, doi:10.1038/ncomms1706. This article has 51 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncomms1706)

6. (Holm2022Anterograde) Anterograde Trafficking of Toll-Like Receptors Requires the Cargo Sorting Adaptors TMED-2 and 7 and specific N-glycans. This article has 0 citations.